Liver Disease Stem Cell Therapy | NSI Stem Cell
By daniellenierenberg
Stem Cell Therapy for Liver Cirrhosis
Chronic Liver Disease is a major concern for the entire country as it ranks as the fifth largest killer in the world. When the liver sustains serious damage, it loses the ability to repair itself and begins to function less and less effectively until it reaches the point that it no longer works, which is a life-threatening condition. An effective liver failure therapy was pursued for decades before the discovery of stem cells offered the possibility of effective liver stem cell therapy. Until the advent of Advanced Liver Stem Cell Therapy, the only therapy option for liver disease was a full organ transplant. Our bone marrow-derived stem cell therapies for liver conditions are an innovative therapy practiced in the United States that is safe and effective.*
We want to see patients with liver disease have a better quality of life and even be able to reverse the damage done. Liver stem cell therapy is one of our latest and most exciting therapies, joining those available at our clinic like stem cell therapy for Neurological or Spinal Cord Conditions.
The liver is a multi-functional organ that plays a role in digestion, blood sugar control, blood clotting factors for healing, making amino acids, increasing red blood cell growth, fat and cholesterol transport, and the removal of waste, especially toxic exposures and the metabolization of medications into their active ingredients. Much research has been done on this vital organ, and we now understand how Liver Stem Cell Therapy can positively impact liver health and function.
A number of things can contribute to Liver Disease. Here are some of the most commonly seen diagnoses in our offices:
Cirrhosis is the medical term that is used to describe liver disease that permanently scars the liver, which results in reduced function, pain, waste build up, and ultimately death of the liver. Its potentially lethal consequences make effective cirrhosis of he liver therapy a matter of the utmost importance.
When this condition is present, normal liver cells are replaced by scar tissue that cannot maintain healthy liver function. Acute liver failure may be life-threatening. Stem Cell Therapy for Liver Cirrhosis is a form of liver cirrhosis therapy that addresses damage as well as helps to generate fresh, healthy tissue.
Not too long ago, a diagnosis of liver failure was a death sentence, as the condition was deemed irreversible. However, new advances in stem cell regeneration have made Liver Stem Cell Therapy, including Stem Cell Therapy for Liver Cirrhosis, a reality.
More than three-quarters of the liver is made up of hepatocyte liver cells, which are special in that their average lifespan is only 150 days. What this means is that the liver is constantly renewing and growing new cells to replace weak and dying cells. It is the only organ in the body that can easily replace damaged cells. But when too many cells are damaged or die off too soon, the liver cannot keep up and it begins to fail into Liver Disease. Helping the organ to grow new cells is one of the functions of NSIs Liver Stem Cell Therapy.
The liver is a regenerative organ. But it is limited in this ability and can only maintain the regenerative pace when there are enough energy, healthy cells, blood, oxygen, and proper nutrients available. Liver Disease can quickly get out of control and can progress to Cirrhosis and Liver Failure very rapidly. Liver Stem Cell Therapy is designed to help reverse this damage and speed the process of cell regeneration.
Although the liver can heal itself, there is a point of no return, and there are not enough signs to indicate there is a problem until it is too late. Prior to Liver Stem Cell Therapy, once the line was crossed between Chronic Liver Disease and the final stage of liver failure, there were few options. Transplantation was the only effective therapy option for liver failure.
But it, too, is not without its share of risks and drawbacks. Rejection of the donor organ, infections, and surgery complications are at the top of the list. It is estimated that for every donor organ, there are 30 patients on a waiting list, and many people die from end-stage Liver Disease waiting for a donor organ.
This is why there has been such a fervent interest in liver failure therapy using stem cells here at NSI Stem Cell Centers.
Going back to as far as the year 2000, researchers have been conducting studies that showed that hepatocyte cells could grow on non-liver cell sources. This means there do not have to be associated liver cells to stimulate the liver cells to continue multiplying. This phenomenon is called transdifferentiation and is integral to Liver Stem Cell Therapy. Our bone marrow-derived stem cell therapies for liver conditions are an innovative therapy practiced in the United States that is safe and effective.*
Today, stem cells that are taken from the patients own fatty deposits are the only stem cells that have successfully been used in addressing liver disease. The major advantage that comes from such stem cells is that they do indeed come from the patient, so rejection is not an issue and there is a much higher success rate and a much-improved growth of new liver cells seen for the patient.
The stem cells are harvested and then transplanted into the damaged liver, where they transdifferentiate into hepatocyte cells. The stem cells also become cells that help with blood and oxygen delivery and waste removal, so the liver can regenerate faster.
To learn more about how Liver Stem Cell Therapy can help you fight your liver disease, contact us today at NSI Stem Cell and set up an appointment at one of our Florida locations. Our phone number is (877) 278-3623, or use our Contact Page. Be sure to ask for our FREE brochure that explains all of our Stem Cell Therapies. We look forward to hearing from you.
Originally posted here:
Liver Disease Stem Cell Therapy | NSI Stem Cell
- Much-anticipated human trial aiming to repair spinal cord damage about to begin - ABC News - October 21st, 2024
- The Science Of Health: Are Spinal Cord Injuries Irreversible? Know Science Advances That Can Cure Them In The Future - ABP Live - October 16th, 2023
- Evaluating the Growth Prospects of the Global Nerve Repair & Regeneration Market at a CAGR of 6.5% | Emergen - EIN News - April 21st, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 17th, 2023
- Kadimastem Submits IND Application to the FDA for its Phase IIa Clinical Trial with AstroRx for the Treatment of ALS - Marketscreener.com - February 21st, 2023
- My Back Is All F*cked Up 55-Year-Old Joe Rogan Curses at Worst Jiu-Jitsu for Painful Health Condition - EssentiallySports - February 21st, 2023
- Brain and Spinal Cord Tumors: Hope Through Research - January 3rd, 2023
- 14.3 The Brain and Spinal Cord Anatomy & Physiology - January 3rd, 2023
- Stem Cell Therapy for Spinal Cord Injury - PubMed - January 3rd, 2023
- Spinal cord injury - Diagnosis and treatment - Mayo Clinic - December 25th, 2022
- Spinal Cord Injury: Hope Through Research | National Institute of ... - December 1st, 2022
- Stem cell controversy - Wikipedia - October 13th, 2022
- Stem Cells Australia | Australian research, stem cell treatments and ... - October 13th, 2022
- The eye and stem cells: the path to treating blindness - October 13th, 2022
- World's first stem cell treatment for spina bifida delivered during fetal surgery - UC Davis Health - October 13th, 2022
- Fighting One Disease or Condition per Day - Daily Kos - October 13th, 2022
- UPDATE: NurExone Signs Letter of Intent with Nanometrix for Its Exosome and Cargo Molecular Profiling AI-Driven Technology - Yahoo Finance - October 13th, 2022
- Global Cell Therapy Market Report (2022 to 2028) - Featuring Thermo Fisher Scientific, MaxCyte, Danaher and Avantor Among Others -... - October 13th, 2022
- Horizon Therapeutics plc Announces New UPLIZNA (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS... - October 13th, 2022
- Physiology, Spinal Cord - StatPearls - NCBI Bookshelf - October 5th, 2022
- IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 ... - October 5th, 2022
- Revolutionary Jab that Could Repair Spinal Cord Injuries Developed by Scientists - Good News Network - October 5th, 2022
- How the 'Love Hormone' Oxytocin May Help Heal Heart Muscles - Healthline - October 5th, 2022
- Unlocking the Mysteries of Brain Regeneration Groundbreaking Study Offers New Insight - SciTechDaily - October 5th, 2022
- In Conversation: How to understand chronic pain - Medical News Today - October 5th, 2022
- New drug could cure aggressive brain cancer stopping tumours in their tracks... - The US Sun - September 27th, 2022
- Rehabilitating spinal cord injury and stroke with graphene and gaming - Nanowerk - September 19th, 2022
- Induced Pluripotent Stem Cells Market Reaches at a CAGR of 8.0% in the Forecast Periods [2021-2031] - BioSpace - September 19th, 2022
- Axolotls can regenerate their brains - Big Think - September 19th, 2022
- IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the... - September 11th, 2022
- Spinal Muscular Atrophy: Causes and importance of early diagnosis for proactive management - Firstpost - September 11th, 2022
- Increasing Road Accidents and Fall Injuries among Aged Population Primarily Driving Need for Orthopedic Navigation Systems: Fact.MR Analysis - Yahoo... - September 3rd, 2022
- Culture of human nasal olfactory stem cells and their extracellular vesicles as advanced therapy medicinal products - Newswise - August 10th, 2022
- Curious kids: what is inside teeth? - The Conversation - August 10th, 2022
- Human placental mesenchymal stem cells derived exosomes improved functional recovery via attenuating apoptosis and increasing axonal regeneration... - August 2nd, 2022
- How the Regenerative Properties of Glioblastoma Can Be Terminated - Gilmore Health News - August 2nd, 2022
- New TSXV listing looks to address the $3B spinal cord injury treatment market (NRX.V) - FXStreet - July 25th, 2022
- Human iPSC co-culture model to investigate the interaction between microglia and motor neurons | Scientific Reports - Nature.com - July 25th, 2022
- Negligence in treatment of diseases like glioblastoma can be fatal, seminar told - The News International - July 25th, 2022
- What lab-grown cerebral organoids are revealing about the brain - New Scientist - July 25th, 2022
- Innovative Therapies, Care Equity Highlight 2022 ASCO Annual Meeting - Targeted Oncology - July 16th, 2022
- Global Stem Cell Manufacturing Market Value Projected To Reach USD 21.71 Billion By 2029, Registering A CAGR Of 9.1% - Digital Journal - July 16th, 2022
- Stem Cell Therapy Market Is Expected To Reach USD 455.61 Billion By 2027 At A CAGR Of 16 percent By Forecast 2027 Says Maximize Market Research (MMR)... - June 30th, 2022
- This startup wants you to have a personal stem cell stash - Freethink - June 30th, 2022
- Parents of 12-Year-Old Boy Praying for a Miracle, Appealing UK Judge's Decision to Remove Life Support - CBN.com - June 30th, 2022
- The end of Roe v. Wade affects more than just abortion - Vox.com - June 30th, 2022
- Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA (inebilizumab) in Brazil - Business Wire - June 20th, 2022
- Effect of Electrical Stimulation on Spinal Cord Injury: In Vitro and In Vivo Analysis - Newswise - June 11th, 2022
- First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting - Newswise - June 11th, 2022
- UK Judge to Decide if 12-Year-Old Will Be Removed from Life Support, Parents Beg for More Time to Heal - CBN.com - June 11th, 2022
- 'This is my life, and I'll try anything to save it': Woman with MS raising funds for treatment - The Brandon Sun - May 29th, 2022
- Racing Thoughts: Quadriplegic Man Drives Race Car With His Brain - Newsy - May 29th, 2022
- Physical therapy for vertigo: Exercises, benefits, and more - Medical News Today - May 29th, 2022
- Researchers find new function performed by almost half of brain cells - Medical News Today - May 13th, 2022
- Texas Family Fights to Access $2.1 Million Treatment for Baby - NBC 5 Dallas-Fort Worth - May 13th, 2022
- Severe COVID-19 may cause cognitive deficits equivalent to 20 years of aging - Medical News Today - May 13th, 2022
- Stem Cell Magic: 5 Promising Treatments For Major Medical Conditions - Study Finds - April 29th, 2022
- Neural Stem Cell Therapy For Spinal Cord Injury To Tap Into The Potential Of Stem Cells - Optic Flux - April 15th, 2022
- Still Blooming: Sams mission to raise money for spinal cord injury research - 7NEWS - April 15th, 2022
- Lineage and Cancer Research UK Announce Completion of Patient Enrollment in Phase 1 Clinical Study of VAC2 for the Treatment of Non-small Cell Lung... - April 15th, 2022
- Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss - Galveston County Daily News - March 22nd, 2022
- COVID-19: Even mild to moderate infection may cause brain anomalies - Medical News Today - March 22nd, 2022
- Scots mum with MS says 50k treatment abroad is 'last hope' of halting disease - Daily Record - January 18th, 2022
- Mending the gap: U of T's Molly Shoichet joins team developing new treatments for spinal cord injuries - News@UofT - January 18th, 2022
- Spinal Cord Injury Information Page | National Institute ... - January 3rd, 2022
- Dancing molecules successfully repair severe spinal cord ... - January 3rd, 2022
- Best 2021 Medical Breakthroughs And Treatments to Beat Cancer, Alzheimer's, Diabetes & More - Good News Network - January 3rd, 2022
- Global Regenerative Medicine Market is Expected to Reach USD 57.08 Billion by 2027, Growing at a CAGR of 11.27% Over the Forecast Period. -... - December 23rd, 2021
- Scientists unravel a gene function that helps the genesis of neurons - Research Matters - December 23rd, 2021
- The 10 Most Compelling Research Stories of 2021 PharmaLive - PharmaLive - December 23rd, 2021
- 2021: The year in review | YaleNews - Yale News - December 23rd, 2021
- Polymyositis Pipeline to Progress with New and Emerging Drugs for Treatment, Analyzes DelveInsight - GlobeNewswire - December 10th, 2021
- Cell and Gene Therapy Market to reach US$ 47,095.2 Mn by end of 2028, Says Coherent Market Insights - PRNewswire - November 22nd, 2021
- From asthma to cancer to infertility, the new treatments, jabs and meds making us healthier... - The Sun - November 22nd, 2021
- Improving motor neuron-like cell differentiation of hEnSCs by the combination of epothilone B loaded PCL microspheres in optimized 3D collagen... - November 8th, 2021
- Akiko Nishiyama Explains the Many Strengths of a Degree in Physiology and Neurobiology - UConn Today - UConn Today - October 28th, 2021
- Team finds way to enhance stem cell therapy for CNS injuries - BioPharma-Reporter.com - October 28th, 2021
- 'Rogue' antibodies found in brains of teens with delusions and paranoia after COVID-19 - Livescience.com - October 28th, 2021
- Traumatic Spinal Cord Injury: An Overview of ... - October 16th, 2021
- Role of Stem Cells in Treatment of Neurological Disorder - October 16th, 2021